Merit and demerit of polyvalent snake antivenoms. Ratanabanangkoon K. J Toxicol Toxin Rev 22(1) p77-89 (2003)

28 Dec 2003
0

Merit and demerit of polyvalent snake antivenoms.
Ratanabanangkoon K.
J Toxicol Toxin Rev 22(1) p77-89 (2003)

Tags

Share this

Related Posts

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)